This inventor holds 135 USPTO granted patents and 33 published patent applications, plus 9 CIPO patents and 8 EPO patents, primarily in Biotherapeutics Development (CPC class A61K39-001). Top assignees: Ecole Polytechnique Federale De Lausanne, The University of Texas System, ETH Zurich. Active years: 1993-2025.
Inventors with similar research interests:
Location History:
- Austin, TX (US) (1993 - 2003)
- Zumiken, CH (2001 - 2005)
- Zumilon, CH (2004 - 2005)
- San Marino, CA (US) (1997 - 2006)
- Concord, MA (US) (1996 - 2008)
- Zumikon, CH (2000 - 2010)
- Zurich, CH (2002 - 2012)
- Epalinges, CH (2012)
- Morges, CH (2008 - 2014)
- Lausanne, CH (2016 - 2019)
- Préverenges, CH (2012 - 2020)
- Preverenges, CH (2016 - 2023)
- Chicago, IL (US) (2018 - 2024)
Company Filing History:
40 out of 714 
32 out of 5,633 
13 out of 555 
Years Active: 1993-2025
Areas of Expertise:
Title: Spotlight on Innovative Inventor Jeffrey Alan Hubbell
Introduction:
Jeffrey Alan Hubbell is a prolific inventor based in Zumikon, Switzerland, with an impressive portfolio of 49 patents to his name. His groundbreaking work in the field of polymeric structures and micelles for nitric oxide delivery has garnered significant attention in the scientific community.
Latest Patents:
1. Two-dimensional polymeric structures - Hubbell's invention focuses on flat membrane-like surfaces or micro-nanostructures containing covalently-bonded monomers of R-substituted metal or metalloid oxides. These structures exhibit a unique crystal architecture with a hexagonal lattice, combining rigidity with bending flexibility, akin to a 'soft' crystal.
2. Micelles for delivery of nitric oxide - Hubbell's innovation involves a vehicle for nitric oxide delivery, utilizing micelles with an internal core comprising a polymer with N-diazeniumdiolate complexed with secondary amines. This method offers a novel approach to nitric oxide administration, potentially revolutionizing therapeutic delivery systems.
Career Highlights:
Hubbell has notably worked with prestigious institutions such as Universität Zürich and Eidgenössische Technische Hochschule Zürich, where his research and inventions have pushed the boundaries of polymer science and biomedical engineering. His contributions have paved the way for advancements in drug delivery systems and biomaterials.
Collaborations:
Throughout his career, Hubbell has collaborated with esteemed colleagues, including Donald Leo Elbert and Jason Schense. Their combined expertise has led to synergistic developments in the field of polymeric structures and biomedical applications, further highlighting Hubbell's multidisciplinary approach to innovation.
Conclusion:
Inventor Jeffrey Alan Hubbell's inventive prowess and relentless pursuit of scientific excellence have established him as a trailblazer in the realms of polymer chemistry and biomedical engineering. His latest patents underscore his commitment to pushing the boundaries of innovation, with potential implications for diverse industries and therapeutic applications.